Copyright
©The Author(s) 2016.
World J Cardiol. Mar 26, 2016; 8(3): 267-276
Published online Mar 26, 2016. doi: 10.4330/wjc.v8.i3.267
Published online Mar 26, 2016. doi: 10.4330/wjc.v8.i3.267
Table 1 Conventional and novel risk factors for atrial fibrillation development and progression
| Well-established risk factors |
| AF (AF begets AF) |
| Valvular heart disease |
| Hypertension |
| Coronary artery disease |
| Heart failure |
| Left atrial dilatation |
| Diabetes mellitus |
| Advancing age |
| Sex (male) |
| Congenital heart disease |
| Acute pericarditis |
| Hyperthyroidism |
| Alcohol consumption |
| Less-established risk factors |
| Obstructive pulmonary disease |
| Obstructive sleep apnea syndrome |
| Obesity |
| Left ventricular diastolic dysfunction |
| Atrial conduction delay (PR interval prolongation) |
| Genetic factors |
| Ethnicity |
| Emerging risk factors |
| Chronic kidney disease |
| Fibrosis |
| Inflammation |
| Elevated natriuretic peptides |
- Citation: Vlachos K, Letsas KP, Korantzopoulos P, Liu T, Georgopoulos S, Bakalakos A, Karamichalakis N, Xydonas S, Efremidis M, Sideris A. Prediction of atrial fibrillation development and progression: Current perspectives. World J Cardiol 2016; 8(3): 267-276
- URL: https://www.wjgnet.com/1949-8462/full/v8/i3/267.htm
- DOI: https://dx.doi.org/10.4330/wjc.v8.i3.267